Proteomics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Proteomics Market: by technology (Protein Microarrays, Spectroscopy, X-ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance) by Component (Reagents & Kits, Instruments, Software & Services) Application (Research Applications, Clinical Applications) End-Users (Pharmaceutical & Biotechnology, Academic & Research Institutes, Diagnostic Laboratories, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Proteomics Market size is estimated to be valued at USD 20,869.2 million in 2021 and is poised to grow at a CAGR of 12.5% over 2022-2028. Proteomics is a technique for identifying and studying proteins implicated in diseases, as well as their expression, activity, and structure. Proteomic research may also be utilized to find prognostic indicators and diagnose cancer, infectious illnesses, malaria, and TB. In the pharmaceutical sector, proteomics is utilized to examine the mechanism of medication action or toxicity. Based on the technology protein microarray segment generated the highest revenue in 2021 in the proteomics market, owing to the technology being widely used to track protein interactions in less time than other technologies. Furthermore, this procedure is required lesser time and is cost-effective. The entire information about DNA/RNA binding proteins can be made available with the use of a protein microarray. Moreover, based on components, the reagents segment accounted for the majority of proteomics market share, it is attributed to the availability of a wide range of reagents and the need for reliable, specific, and fast detection of diseases at the early stages as they are extensively utilized in primary screening in drug discovery and microarray technologies. Increasing demand for factors like rising demand for personalized medicine, increasing R&D expenditure, government funding for proteomics, and technological advancements driving the market growth over the forecast years.

Recent Market Developments:

In Feb 2021, Agilent Technologies Inc. launched Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.

Proteomics Market

MARKET SUMMARY
-
12.5% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 12.5%
  • Largest Market– North America
  • Fastest Growing Market–  Europe

Proteomics Market

  • The report on global proteomics market gives historical, current and future market sizes (US$ Bn) based on product type, application, service type, and end user and geographical regions.
  • Proteomics Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Bruker Corporation
  • Bio-Rad Laboratories
  • PerkinElmer
  • GE Healthcare
Proteomics Market

Dynamics

The market is expected to offer lucrative opportunities due to increase research and development programs and increase biotech expenditure attributing to coronavirus driving the global proteomic market growth. Moreover, due to technological advancement, increase in research funding, growing healthcare spending, demand for customized medicine, and rise in the prevalence of genetic diseases also immense boost to the market over the forecast years.


North-America Got Significant Share

Proteomics Market

North America has the largest share in the global proteomics market and the market is expected to grow at a significant CAGR over the forecast years owing to increasing investments in personalized medicine, the existence of global market leaders, increased research in the disciplines of omics, and increased investments in structure-based drug design. Moreover, Asia Pacific is also likely to show significant growth over the forecasting period owing to rise in prevalence of genetic disease, increase in R&D expenditure, and expansion of business by the market players into the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The Proteomics market report provides granular level information about the market size, regional market share, historic market (2016-2021) and forecast (2022-2028)
  • The Proteomics market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The Proteomics market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The Proteomics market report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The Proteomics market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Proteomics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The CAGR of the proteomics market is 12.5% over the forecast period (2022 – 2028)

Thermo Fisher Scientific, Agilent Technologies, Bruker Corporation, Bio-Rad Laboratories, PerkinElmer

 

The Asia Pacific is the fastest-growing region for the proteomics market


Report

Table Of Content

1. Executive Summary
2. Global Proteomics Market Introduction
2.1. Global Proteomics Market – Taxonomy
2.2. Global Proteomics Market –Definitions
2.2.1. Technology
2.2.2. Component
2.2.3. Application
2.2.4. End User
3. Global Proteomics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Proteomics Market Dynamic Factors – Impact Analysis
3.6. Global Proteomics Market – Competition Landscape
3.7. Epidemiology
4. Global Proteomics Market Analysis,2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Proteomics Market, By Technology, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Protein Microarrays
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Spectroscopy
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. X-ray Crystallography
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Chromatography
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Electrophoresis
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Surface Plasmon Resonance
5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Proteomics Market Forecast, By Component, 2017 – 2021 and Forecast, 2022 – 2028(Revenue, USD Mn)
6.1. Reagents & Kits
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Instruments
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Software & Services
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Proteomics Market Forecast, By Application, 2017 – 2021 and Forecast, 2022 – 2028(Revenue, USD Mn)
7.1. Research Applications
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Clinical Applications
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Proteomics Market, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. Pharmaceutical & Biotechnology
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Academic & Research Institutes
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Diagnostic Laboratories
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Proteomics Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Proteomics Market – Opportunity Analysis Index, By Technology, Component, Application and Region,  2022 – 2028
10. North America Proteomics MarketAnalysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. By Technology Analysis 2017 – 2021 and Forecast, 2022 – 2028byRevenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Protein Microarrays
10.1.2. Spectroscopy
10.1.3. X-ray Crystallography
10.1.4. Chromatography
10.1.5. Electrophoresis
10.1.6. Surface Plasmon Resonance
10.2. Component Analysis 2017 – 2021 and Forecast  2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Reagents & Kits
10.2.2. Instruments
10.2.3. Software & Services
10.3. Application Analysis 2017 – 2021 and Forecast  2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Research Applications
10.3.2. Clinical Applications
10.4. End User Analysis 2017 – 2021 and Forecast  2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical & Biotechnology
10.4.2. Academic & Research Institutes
10.4.3. Diagnostic Laboratories
10.4.4. Others
10.5. Country Analysis 2017 – 2021 and Forecast, 2022 – 2028byRevenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Proteomics Market – Opportunity Analysis Index, By Technology, Component, Application, and Country,  2022 – 2028
10.7. North America Proteomics Market Dynamics – Trends
11. Europe Proteomics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. By Technology Analysis 2017 – 2021 and Forecast, 2022 – 2028byRevenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Protein Microarrays
11.1.2. Spectroscopy
11.1.3. X-ray Crystallography
11.1.4. Chromatography
11.1.5. Electrophoresis
11.1.6. Surface Plasmon Resonance
11.2. Component Analysis 2017 – 2021 and Forecast  2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Reagents & Kits
11.2.2. Instruments
11.2.3. Software & Services
11.3. Application Analysis 2017 – 2021 and Forecast  2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Research Applications
11.3.2. Clinical Applications
11.4. End User Analysis 2017 – 2021 and Forecast  2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical & Biotechnology
11.4.2. Academic & Research Institutes
11.4.3. Diagnostic Laboratories
11.4.4. Others
11.5. Country Analysis 2016 – 2020 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Proteomics Market – Opportunity Analysis Index, By Technology, Component, Application, and Country,  2022 – 2028
11.7. Europe Proteomics Market Dynamics – Trends
12. Asia-Pacific Proteomics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. By Technology Analysis 2017 – 2021 and Forecast, 2022 – 2028byRevenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Protein Microarrays
12.1.2. Spectroscopy
12.1.3. X-ray Crystallography
12.1.4. Chromatography
12.1.5. Electrophoresis
12.1.6. Surface Plasmon Resonance
12.2. Component Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Reagents & Kits
12.2.2. Instruments
12.2.3. Software & Services
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Research Applications
12.3.2. Clinical Applications
12.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical & Biotechnology
12.4.2. Academic & Research Institutes
12.4.3. Diagnostic Laboratories
12.4.4. Others
12.5. Country Analysis2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Proteomics Market – Opportunity Analysis Index, By Technology, Component, Application, and Country,  2022 – 2028
12.7. Asia-Pacific Proteomics Market Dynamics – Trends
13. Latin America Proteomics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. By Technology Analysis 2017 – 2021 and Forecast, 2022 – 2028byRevenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Protein Microarrays
13.1.2. Spectroscopy
13.1.3. X-ray Crystallography
13.1.4. Chromatography
13.1.5. Electrophoresis
13.1.6. Surface Plasmon Resonance
13.2. Component Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Reagents & Kits
13.2.2. Instruments
13.2.3. Software & Services
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Research Applications
13.3.2. Clinical Applications
13.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical & Biotechnology
13.4.2. Academic & Research Institutes
13.4.3. Diagnostic Laboratories
13.4.4. Others
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Proteomics Market – Opportunity Analysis Index, By Technology, Component, Application, and Country,  2022 – 2028
13.7. Latin America Proteomics Market Dynamics – Trends
14. Middle East and Africa Proteomics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
14.1. By Technology Analysis 2017 – 2021 and Forecast, 2022 – 2028byRevenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
14.1.1. Protein Microarrays
14.1.2. Spectroscopy
14.1.3. X-ray Crystallography
14.1.4. Chromatography
14.1.5. Electrophoresis
14.1.6. Surface Plasmon Resonance
14.2. Component Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Reagents & Kits
14.2.2. Instruments
14.2.3. Software & Services
14.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Research Applications
14.3.2. Clinical Applications
14.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical & Biotechnology
14.4.2. Academic & Research Institutes
14.4.3. Diagnostic Laboratories
14.4.4. Others
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Proteomics Market – Opportunity Analysis Index, By Technology, Component, Application, and Country,  2022 – 2028
14.7. MEA Proteomics Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Component& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Thermo Fisher Scientific Inc.
15.2.2. Bio-Rad Laboratories, Inc.
15.2.3. Danaher
15.2.4. PerkinElmer Inc.
15.2.5. Luminex Corporation
15.2.6. Creative Proteomics
15.2.7. Agilent Technologies, Inc.
15.2.8. Bruker Corporation
16. Research Methodology
17. Key Assumptions and Acronyms


Report

Company Profile

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • GE Healthcare
  • Merck KGaA
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

Description

Proteomics Market size is estimated to be valued at USD 20,869.2 million in 2021 and is poised to grow at a CAGR of 12.5% over 2022-2028. Proteomics is a technique for identifying and studying proteins implicated in diseases, as well as their expression, activity, and structure. Proteomic research may also be utilized to find prognostic indicators and diagnose cancer, infectious illnesses, malaria, and TB. In the pharmaceutical sector, proteomics is utilized to examine the mechanism of medication action or toxicity. Based on the technology protein microarray segment generated the highest revenue in 2021 in the proteomics market, owing to the technology being widely used to track protein interactions in less time than other technologies. Furthermore, this procedure is required lesser time and is cost-effective. The entire information about DNA/RNA binding proteins can be made available with the use of a protein microarray. Moreover, based on components, the reagents segment accounted for the majority of proteomics market share, it is attributed to the availability of a wide range of reagents and the need for reliable, specific, and fast detection of diseases at the early stages as they are extensively utilized in primary screening in drug discovery and microarray technologies. Increasing demand for factors like rising demand for personalized medicine, increasing R&D expenditure, government funding for proteomics, and technological advancements driving the market growth over the forecast years.

Recent Market Developments:

In Feb 2021, Agilent Technologies Inc. launched Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX